GNMK News and Press, GenMark Diagnostics Inc. From 08/27/20

Several stocks of companies that make COVID-19 diagnostic tests were sinking on Thursday following big news from Abbott Laboratories (NYSE: ABT) on Wednesday evening. Abbott announced that it received FDA emergency use authorization (EUA) for a COVID-19 antibody test that costs $5 and provi...

COVID-19 test and equipment makers are slipping premarket - and Abbott Laboratories (NYSE: ABT ) is up 9.5% , setting it its best day in months - following last evening's FDA approval of Abbott's quick, inexpensive test for the disease . More news on: Abbott Laboratories, Quidel Corpor...

TRACON Pharmaceuticals gets FDA clearance for ENVASARC pivotal trial TRACON Pharmaceuticals ( TCON ) announced that the FDA has given its nod for a pivotal trial. The company had submitted the protocol as a part of its Investigational New Drug application with the FDA on July 15, 2020. T...

GenMark Diagnostics (NASDAQ: GNMK ) has filed an application with the FDA seeking emergency use authorization for its eSensor SARS-CoV-2 Test, a molecular assay that detects the presence of the coronavirus. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Stocks on the ...

CARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that it has notified the U.S. Food and Drug Administration (FDA) of the intent to commercially distribute ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

I have separated my long-running Investor section from Weighing the Week Ahead. My hope is to highlight ideas for the long-term investor. In my last investment post I applied the key concepts of the matrix to a range of investment ideas. We have been on target so far with what to avoid, and ...

Investment Thesis GenMark Diagnostics (GNMK) is an active investment alternative in competition with dozens of other medical diagnostic and research enterprises. Success from an investment point of view relates more to increased stock price than lives saved. That measure here rests importa...

FinancialBuzz.com News Commentary New York, NY (8/6/2020) – The diagnostics industry is highly diverse, with a vast number of testing methods already on the market and a consistent flow of new technologies. In fact, diagnostics are no longer just about the detection of diseases, and now...

The poor control of COVID-19 in the United States has created an unprecedented testing opportunity for GenMark ( GNMK ), and so far the company is doing a good job of leveraging that opportunity to get hardware in the field and establish relationships with healthcare facilities that may well...